DANIEL GLAZE to Neuroprotective Agents
This is a "connection" page, showing publications DANIEL GLAZE has written about Neuroprotective Agents.
Connection Strength
0.479
-
A Double-Blind, Randomized, Placebo-Controlled Clinical Study of Trofinetide in the Treatment of Rett Syndrome. Pediatr Neurol. 2017 Nov; 76:37-46.
Score: 0.479
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.